Stage IV Anal Cancer Completed Phase 1 Trials for Irinotecan (DB00762)

Also known as: Anal cancer stage IV / Anal carcinoma stage IV / Anal canal cancer stage IV

IndicationStatusPhase
DBCOND0028760 (Stage IV Anal Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000316817-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Treatment